Viewing nowJW Atorvastatin 10 mg Tablets (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

MFDS item code 201701097 · Approved 2017.02.28 · Insurance code 052701080
Improvement of hyperlipidemia (e.g., pediatric familial hypercholesterolemia); prevention of cardiovascular disease
This medication is used for adult and pediatric patients with risk factors for cardiovascular disease. It helps reduce the risk of cardiovascular diseases such as coronary heart disease, myocardial infarction, stroke, and angina, as well as aiding in recovery after vascular procedures and reducing hospitalizations due to congestive heart failure. Additionally, it effectively lowers cholesterol, LDL-cholesterol, Apo-B proteins, and triglyceride levels in patients with primary and familial hyperlipidemia, and increases HDL-cholesterol, contributing to the management of blood lipids. For these reasons, this medication is safely and effectively used as a dietary adjunct for the management of cardiovascular diseases and dyslipidemia.
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, for patients requiring a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (40 mg is only for patients requiring an LDL cholesterol reduction of 45 % or greater). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to reduce LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are similar to those in the general adult population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). Dose adjustments should be made at intervals of 4 weeks or longer.
This medication has the potential to cause muscle-related abnormalities, so if symptoms like muscle pain or weakness occur, treatment should be immediately stopped and a doctor consulted. There are patients who should not take this medication. For example, individuals who are allergic to this medication or its components, have active liver disease, have severe muscle diseases, are pregnant or nursing, children under 10 years of age, or those on certain other medications should not use this medication. Patients with liver or kidney function issues should be cautious when taking this medication and undergo regular tests to monitor liver and kidney status. This medication might affect liver function, so if symptoms of hepatitis or liver dysfunction are suspected, the doctor should be notified immediately and the medication should be discontinued. During treatment, if symptoms like muscle pain, weakness, fever, etc., occur, the healthcare provider should be notified immediately, and blood tests may be required to check for muscle damage. This medication may interact with certain drugs, increasing the risk of side effects, so if other medications are being taken, the doctor or pharmacist must be informed. Particularly, caution is required when used with certain antibiotics, antifungal agents, antiviral agents, some antihypertensives, and fibrate drugs. Women taking this medication who are planning to become pregnant should use appropriate contraception and discontinue use immediately upon confirmation of pregnancy. This medication is not recommended for women who are breastfeeding, and discontinuing breastfeeding is advised. Elderly patients or those with decreased kidney function have a higher risk of muscle-related side effects, and should be particularly careful while taking this medication. In case of overdose, there is no specific antidote, and treatment should follow the symptoms while regularly monitoring liver and muscle conditions. This medication should be kept out of reach of children and stored in its original container, avoiding transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container, away from air and moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius. This will help maintain the medication's efficacy and safety.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.